Drug: Omalizumab Injury: Asthma Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
89912543 | Omalizumab | Asthma | ROCHE | 58.05 YR | F | 138 KG | 20160811 | CA |
90309804 | Omalizumab | Asthma | ROCHE | 35.80 YR | F | 77 KG | 20160815 | CN |
112950264 | Omalizumab | Asthma | ROCHE | 56.00 YR | F | 78 KG | 20160812 | DE |
122702492 | Omalizumab | Asthma | ROCHE | 25.00 YR | F | 0 | 20160728 | PL |
124273042 | Omalizumab | Asthma | ROCHE | 12.19 YR | M | 29 KG | 20160728 | JP |
125474982 | Omalizumab | Asthma | ROCHE | 25.11 YR | F | 0 | 20160823 | JP |
126718501 | Omalizumab | Asthma | ROCHE | 20.59 YR | F | 0 | 20160822 | US |
727460313 | Omalizumab | Asthma | ROCHE | 49.08 YR | F | 56 KG | 20160708 | JP |
Total Records: 8 Number of Pages: 1